PL2203457T3 - Przeciwmalaryczne dispiro-1,2,4-trioksolany - Google Patents

Przeciwmalaryczne dispiro-1,2,4-trioksolany

Info

Publication number
PL2203457T3
PL2203457T3 PL08845311T PL08845311T PL2203457T3 PL 2203457 T3 PL2203457 T3 PL 2203457T3 PL 08845311 T PL08845311 T PL 08845311T PL 08845311 T PL08845311 T PL 08845311T PL 2203457 T3 PL2203457 T3 PL 2203457T3
Authority
PL
Poland
Prior art keywords
dispiro
trioxolane antimalarials
trioxolane
antimalarials
Prior art date
Application number
PL08845311T
Other languages
English (en)
Inventor
Jonathan L Vennerstrom
Yuxiang Dong
Susan A Charman
Sergio Wittlin
Jacques Chollet
Darren J Creek
Xiaofang Wang
Kamaraj Sriraghavan
Lin Zhou
Hugues Matile
William N Charman
Original Assignee
Medicines For Malaria Venture Mmv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicines For Malaria Venture Mmv filed Critical Medicines For Malaria Venture Mmv
Publication of PL2203457T3 publication Critical patent/PL2203457T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
    • C07D323/02—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL08845311T 2007-10-31 2008-10-29 Przeciwmalaryczne dispiro-1,2,4-trioksolany PL2203457T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/930,606 US8067620B2 (en) 2005-05-04 2007-10-31 Dispiro 1,2,4-trioxolane antimalarials
EP08845311.3A EP2203457B1 (en) 2007-10-31 2008-10-29 Dispiro 1,2,4-trioxolane antimalarials
PCT/US2008/081579 WO2009058859A2 (en) 2007-10-31 2008-10-29 Dispiro 1,2,4-trioxolane antimalarials

Publications (1)

Publication Number Publication Date
PL2203457T3 true PL2203457T3 (pl) 2014-08-29

Family

ID=40228026

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08845311T PL2203457T3 (pl) 2007-10-31 2008-10-29 Przeciwmalaryczne dispiro-1,2,4-trioksolany

Country Status (20)

Country Link
US (1) US8067620B2 (pl)
EP (1) EP2203457B1 (pl)
JP (1) JP5559057B2 (pl)
KR (1) KR101588468B1 (pl)
CN (1) CN101842377B (pl)
AU (1) AU2008318819C1 (pl)
BR (1) BRPI0818121B8 (pl)
CA (1) CA2702256C (pl)
CY (1) CY1115148T1 (pl)
DK (1) DK2203457T3 (pl)
ES (1) ES2466319T3 (pl)
HK (1) HK1147092A1 (pl)
HR (1) HRP20140435T1 (pl)
MX (1) MX2010004601A (pl)
PL (1) PL2203457T3 (pl)
PT (1) PT2203457E (pl)
RU (1) RU2493159C2 (pl)
SI (1) SI2203457T1 (pl)
UA (1) UA99742C2 (pl)
WO (1) WO2009058859A2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8067620B2 (en) 2005-05-04 2011-11-29 Medicines For Malaria Venture Mmv Dispiro 1,2,4-trioxolane antimalarials
SG192144A1 (en) 2011-01-31 2013-08-30 Bristol Myers Squibb Co C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity
WO2013186153A2 (en) * 2012-06-13 2013-12-19 Medizinische Universität Wien Amidophenoxypropanolamines
EP3104857A4 (en) 2014-02-14 2017-10-11 The Regents of The University of California Cyclic peroxides as prodrugs for selective delivery of agents
EP3309156A1 (en) 2016-10-13 2018-04-18 MMV Medicines for Malaria Venture New anti-malarial agents
JP2019530712A (ja) 2016-10-13 2019-10-24 エムエムヴィ メディシンズ フォア マラリア ヴェンチャーＭｍｖ Ｍｅｄｉｃｉｎｅｓ Ｆｏｒ Ｍａｌａｒｉａ Ｖｅｎｔｕｒｅ 新規抗マラリア薬
US11246854B2 (en) * 2017-05-16 2022-02-15 The Johns Hopkins University Ozonides for treating or preventing virus infections
US11072594B2 (en) 2017-06-27 2021-07-27 The Regents Of The University Of California Trioxolane agents
CN110878069A (zh) * 2019-12-09 2020-03-13 南京杰运医药科技有限公司 一种4-吗琳基-2-乙基哌嗪的制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3621062A (en) 1966-10-25 1971-11-16 Sterling Drug Inc 2-(8-cyclohexyloctanoyl or 7-cyclohexylheptanoyl)-1-naphthol
US3673222A (en) 1969-11-26 1972-06-27 Sydney Archer 2-(8-cyclohexyloctyl or 7-cyclohexylheptyl)-1,4-naphthoquinone and process for preparation and use thereof
US3682991A (en) 1970-10-19 1972-08-08 Sterling Drug Inc 3,3,5-trimethylcyclohexyl-alkyl-carboxylic acids
US4978678A (en) * 1986-11-20 1990-12-18 Hoechst-Roussel Pharmaceuticals Inc. 12-halogenated forskolin derivatives
US4916204A (en) 1987-07-31 1990-04-10 Massachusetts Institute Of Technology Pure polyanhydride from dicarboxylic acid and coupling agent
US4816478A (en) 1987-08-24 1989-03-28 Thornfeldt Carl R Treatment of acquired immunodeficiency syndrome
US5053342A (en) 1987-12-24 1991-10-01 Litmus Concepts, Inc. Fecal occult blood test reagents
US5559145A (en) 1988-06-01 1996-09-24 Oxaco S.A. 1,2,4-trioxane derivatives
US5270344A (en) 1988-06-24 1993-12-14 Stephen Herman Method of treating a systemic disorder using trioxolane and diperoxide compounds
JP2867529B2 (ja) 1990-01-22 1999-03-08 三菱電機株式会社 投写型表示装置
US5216175A (en) 1990-03-23 1993-06-01 Sri International Antimalarial analogs of artemisinin
US5219880A (en) 1991-03-29 1993-06-15 Dermatologic Research Corporation Treatment of viral tumors and hemorrhoids with artemisinin and derivatives
US5510356A (en) 1991-10-03 1996-04-23 University Of Nebraska Board Of Regents Bisquinolines and processes for their production and use to treat malaria
US5171676A (en) 1991-10-31 1992-12-15 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of introducing hydroxyl groups into artemisinin and its derivatives
US5430148A (en) 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
KR950702436A (ko) 1992-07-28 1995-07-29 자코부스 코르넬리스 라세르 가교 결합 양이온성 중합체 및 알콜실화 에테르를 함유하는 국소용 약학 조성물(pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether)
US5721209A (en) 1995-02-03 1998-02-24 The Regents Of The University Of California Iron chelator and inhibitor of iron-mediated oxidant injury
US5780675A (en) 1995-04-28 1998-07-14 The University Of New Mexico Deoxygossylic compounds
US5578637A (en) 1995-05-03 1996-11-26 University Of Washington Methods of inhibition or killing cancer cells using an endoperoxide
US5672624A (en) 1995-11-22 1997-09-30 The Johns Hopkins University Endoperoxides useful as antiparasitic agents
US5817692A (en) 1995-11-22 1998-10-06 The Johns Hopkins University Endoperoxides useful as antiparasitic agents
US5932591A (en) 1996-12-02 1999-08-03 Johns Hopkins University C3 substituted trioxanes useful as antiparasitic drugs
US6486199B1 (en) * 2001-06-21 2002-11-26 Medicines For Malaria Venture Mmv International Centre Cointrin Spiro and dispiro 1,2,4-trioxolane antimalarials
US20080125441A1 (en) * 2002-06-21 2008-05-29 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US6906205B2 (en) * 2002-06-21 2005-06-14 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US6825230B2 (en) * 2002-06-21 2004-11-30 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trixolane antimalarials
US7371778B2 (en) * 2002-06-21 2008-05-13 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US8067620B2 (en) * 2005-05-04 2011-11-29 Medicines For Malaria Venture Mmv Dispiro 1,2,4-trioxolane antimalarials
PT1898901T (pt) * 2005-05-18 2017-02-27 Sun Pharmaceutical Ind Ltd Formas de dosagem estáveis de antimaláricos de espiro- e diespiro-1,2,4-trioxolano

Also Published As

Publication number Publication date
BRPI0818121B1 (pt) 2020-12-08
CA2702256A1 (en) 2009-05-07
JP5559057B2 (ja) 2014-07-23
EP2203457A2 (en) 2010-07-07
ES2466319T3 (es) 2014-06-17
CY1115148T1 (el) 2016-12-14
UA99742C2 (en) 2012-09-25
BRPI0818121A2 (pt) 2015-11-17
SI2203457T1 (sl) 2014-06-30
RU2010121919A (ru) 2011-12-10
US8067620B2 (en) 2011-11-29
KR101588468B1 (ko) 2016-01-25
CN101842377A (zh) 2010-09-22
BRPI0818121B8 (pt) 2021-05-25
KR20100087199A (ko) 2010-08-03
HRP20140435T1 (hr) 2014-06-20
JP2011502131A (ja) 2011-01-20
RU2493159C2 (ru) 2013-09-20
MX2010004601A (es) 2010-05-27
DK2203457T3 (da) 2014-05-12
WO2009058859A2 (en) 2009-05-07
AU2008318819C1 (en) 2014-04-24
PT2203457E (pt) 2014-06-06
EP2203457B1 (en) 2014-03-05
AU2008318819A1 (en) 2009-05-07
WO2009058859A3 (en) 2009-06-18
CN101842377B (zh) 2015-07-01
HK1147092A1 (en) 2011-07-29
US20080125411A1 (en) 2008-05-29
CA2702256C (en) 2017-09-26
AU2008318819B2 (en) 2013-11-21

Similar Documents

Publication Publication Date Title
IL201973A0 (en) 3,3-spiroindolinone derivatives
IL206765A0 (en) 4,5-dihydro-oxazol-2-yl-amine derivatives
ZA201001797B (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
HK1147092A1 (en) Dispiro 1,2,4-trioxolane antimalarials 124-
IL225694A0 (en) Compounds 6,5- dihydro-h1-pyridine-2-one
EP2136810A4 (en) NOVEL 1,8-NAPHTHYRIDINE COMPOUNDS
ZA201000428B (en) Desalination
SI2356123T1 (sl) Piro-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo(e)azuleni
IL200863A0 (en) Novel uses
GB0820231D0 (en) Airbagmodul, airbagmodulanordung und befestigungsverfahren
EP2202231A4 (en) 2,3-DIHYDROIMINOISOINDOLE DERIVATIVE
GB0702228D0 (en) The cosy-cushion
IL201444A0 (en) New 4, 8 - diphenyl - polyazanaphthalene derivatives
GB0707146D0 (en) The bealyboard
HK1162032A1 (en) 1,1,1-trifluoro-2-hydroxypropyl compounds 111--2-
HK1161684A1 (en) 5,6-dihydro-1h-pyridin-2-one compounds 56- -1h--2-
IL194972A0 (en) 2-alkoxy-3,4,5-trihydroxy-alkylamide-
GB0719111D0 (en) T.m.2
GB0711387D0 (en) The fincubator
GB0701309D0 (en) The easi-strutt
GB0701036D0 (en) .
GB0701035D0 (en) .
IL181852A0 (en) D.s-hom
GB0804523D0 (en) L.g.d
GB0720590D0 (en) T.m.3